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INTRODUCTION
Crohn’s disease (CD) is an inflammatory bowel disease that 
can affect the entire gastrointestinal tract, with the small bo-
wel (SB) being the most commonly affected site. The terminal 
ileum is the most common area affected by CD and it is usu-
ally accessible at the time of colonoscopy. However, proximal 
SB may be the only area of the gastrointestinal tract affected 
in approximately one third of patients with ileocolonic CD.1 
In some patients, refractory inflammation or chronic stric-
tures of the SB are responsible for a debilitating course of the 
disease that might lead to malnutrition and a severely reduced 
quality of life. Therefore, the SB warrants special attention in 
diagnosis and treatment of CD,2 and SB evaluation can also be 
helpful in differentiation of CD from inflammatory bowel dise-
ase of unclassified type.3,4
The SB lesions have transitionally been difficult to evaluate 
because of their inaccessibility to endoscopic exploration. In-
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deed, until recently, the endoscopic visualization of the SB was 
limited to the terminal ileum during colonoscopy and to the 
very proximal jejunum during push enteroscopy. The majority 
of the SB was not seen endoscopically and was evaluated with 
radiologic tests such as traditional radiological techniques 
(SB follow-through) in the diagnosis and management of CD. 
In the last few years, the SB has come within reach of easy-
to-apply endoscopy, that is, wireless video capsule (SB capsule 
endoscopy; SBCE) and device-assisted enteroscopy (DAE). 
In addition, several radiological techniques including com-
puted tomography enterography (CTE) or magnetic reson-
ance enterography (MRE) are now available for the evaluation 
of the SB. Each technology has its own strengths and weak-
nesses. They should be viewed as complementary studies and 
not mutually exclusive. The recent development of innovative 
imaging techniques has opened a new and exciting area in the 
exploration of the SB in CD patient. Among them, what is the 
best endoscopic or radiologic approach for the diagnosis and/
or management of CD? Here, SB endoscopy and radiology in 
suspected and known CD patients will be addressed and dis-
cussed in detail. 
SB ENDOSCOPY
SBCE
In 2000, Iddan et al.5 at Given Imaging published on a cam-
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era pill aimed at imaging the mucosal lining of the small in-
testine. By 2001, this capsule endoscope was officially approved 
by the United States Food and Drug Administration and was 
used on humans outside the clinical trials.
At present, there are several commercially available SBCE 
systems on the market that differ somehow in terms of tech-
nical details or software features: Miro-Cam, IntroMedic, 
Seoul, Korea (http://www.intromedic.com/); PillCam SB2, 
Given Imaging, Yoqneam, Israel (http://www.givenimaging.
com/); EndoCapsule, Olympus Europe GmbH, Hamburg, 
Germany (http://www.olympuseuropa.com/endoscopy/); 
CapsoVision, Saratoga, CA, USA (http://www.capsovision.
com/); OMOM, Chongqing Jinshan Science, Beijing, China 
(http://www. cqjs.net/) (Table 1). 
SBCE offers a noninvasive and easy-to-apply investigation 
of the SB. The video capsule is ingested and passes the intes-
tinal tract by natural peristalsis, so SBCE does not have the 
ability to clean the mucosa or eliminate debris, bubbles, or bile 
during the procedure. Although bowel preparation should be 
used, there is no international consensus about patient prep-
aration for SBCE.
Diagnosis of terminal ileal CD can be usually made at ileo-
colonoscopy, which should be performed before SBCE. A nor-
mal SBCE has a high negative predictive value (96% to 100%) 
for active SB CD. In other words, an unremarkable SBCE 
evaluation virtually excludes SB CD.6,7 Numerous articles sh-
owed the superiority of SBCE to barium studies or push en-
teroscopy in detecting lesions for SB evaluations. The latest 
meta-analysis demonstrated a significantly increased diag-
nostic yield with SBCE compared with SB follow-through, 
CTE, and ileocolonoscopy in patients with suspected CD or 
known CD, but only in patients with established nonstrictur-
ing CD being evaluated for SB involvement.8-10 Many pro-
spective trials, including multicenter study conducted by Ko-
rean Capsule Endoscopy Study Group, have shown superi-
ority of SBCE over SB follow-through for the evaluation of 
SB lesions.11 SBCE allows earlier diagnosis of CD of the SB and 
improves the diagnosis of colitis in patients in whom it is un-
clear whether the issue is CD or ulcerative colitis .
Although there are many advantages of SBCE, the main 
limitation of SBCE is the lack opportunity to take biopsies or 
to perform interventions, the difficulty to exactly localize iden-
tified lesions, and to control its movement. And SBCE shows 
high rate incidental findings, limited diagnostic accuracy in 
second portion of duodenum, and 25% of failure rate to reach 
cecum. 
Persistent capsule retention is the feared major complica-
tion of SBCE. The incidence of capsule retention in the gener-
al population is between 1% and 2.5%, predominantly because 
of capsule retention at focal sites of intestinal stenosis. The in-
cidence of capsule retention in cases of suspected CD was 
1.6% in a previous study.12 On the other hand, capsule reten-
tion rate as high as 13% have been reported in patients with 
known CD.12 In a recent large-scale study, known CD was a 
risk factor for capsule retention (odds ratio, 9.39; 95% confi-
dence interval, 3.32 to 26.54).13 Because of a propensity for in-
testinal strictures to develop, patients with CD are at increas-
ed risk of persistent capsule retention. For this reason, radio-
logic imaging of the SB is often recommended before SBCE. 
However, it is important to note that even in the presence of 
normal SB radiologic findings, there can still be significant un-
detected strictures. In an effort to avoid capsule retention, a 
dissolving test capsule called a patency capsule has been de-
veloped. This patency capsule is the same size as the SBCE. It 
is constructed of cellophane with a wax plug and a radiotag, 
which enables external scanning to verify its presence in the 
body. Data on a recently developed patency capsule suggest 
that it may significantly reduce (if not eliminate) the risk of 
complications and perhaps obviate the need for preliminary 
SB imaging. Patients with known CD should be informed 
before SBCE that despite of normal imaging they remain at 
risk of capsule retention.10 Because it is a metallic device, mag-
netic resonance (MR) imaging testing should not be perform-
ed until capsule passage is ensured clinically or radiologically. 
A warning remains against performing SBCE in patients 
with cardiac pacemakers or other implanted electromedical 
devices. However, recent data show no significant interaction 
between SBCE and pacemakers or implantable cardioversion 
devices.14-16 Capsule aspiration is a rare but potentially serious 
complication.17 Finally, intestinal perforation within a short 
Table 1. Five Capsule Endoscopes Are Available at Present
Capsule Company Size, mm
Frame rate, 
images/sec
Field of view Acquisition time, hr
MiroCam IntroMedic, Korea 25×11 3 - >11
PillCam SB 2 Given Imaging, Israel 26×11 2 156° 8 (SB 2); 12-16 (SB 2L)
EndoCapsule Olympus, Japan 26×11 2 145° >8
OMOM Chongqing Jinshan Science, China 28×13 2 or 1 140° 8
CapsoVision CapsoVision Inc., USA 31×11.3 0-5 360° 15
SB, small bowel.
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time after capsule ingestion has been reported in a few patients 
with previously undiagnosed Crohn’s strictures.18-20
 
DAE 
Balloon-assisted enteroscopy (BAE)
Soon after capsule endoscopy was invented, Yamamoto et 
al.21 published his article on modifying a colonocope to per-
form a total enteroscopy using a two balloon system and an 
overtube. A commercial grade double balloon enteroscopy 
(DBE) scope and processor with safety controls was then de-
veloped by Fujinon, Saitama, Japan. to identify and treat SB 
conditions. BAE allows deeper intubation of the SB compar-
ed with push enteroscopy and ileocolonoscopy. BAE involves 
push-and-pull maneuvers for deep intubation of the SB, and 
single balloon enteroscope (SBE) and DBE are presently avail-
able (Table 2).2 SBE is virtually identical to the DBE except for 
its use of silicone material for the balloon and overtube and 
lack of the inflantable endoscope balloon. Rate of complete 
SB investigations seems to be more regularly achievable us-
ing double balloon instead of single balloon technique as re-
ported in randomized studies, but therapeutic impact was 
similar between SBE and DBE. In patients with known CD, 
adhesion may limit examination by BAE, and in these cir-
cumstances, DBE may be preferred for the SB evaluation.
There are not enough data to recommend BAE, unless con-
ventional studies including ileocolonoscopy and radiographic 
imaging of the SB have been inconclusive and histological di-
agnosis would alter disease management. The advantages of 
BAE compared with SBCE include the evaluation of atypical 
lesions, the ability to obtain biopsies for histopathology, and 
the potential for therapeutic intervention (e.g., dilation, re-
trieving foreign body, or treatment of bleeding lesions).22 The 
decision on whether SBCE or BAE should be performed first 
depends on the nature and location of the SB lesion, as well as 
local availability and expertise in suspected CD patients. So-
metimes, SBCE provides information on the optimal route of 
approach (i.e., oral or rectal) by subsequent BAE.8
Despite of the advantages of BAE such as direct (real-time) 
inspection, biopsy, or therapeutic capabilities, BAE has a sig-
nificant risk of complication (<5%). There is a close to 1% ch-
ance of complication in performing a diagnostic procedure, 
with pancreatitis being the most common issue. As expected, 
endoscopic treatment may lead to much higher change of per-
foration and bleeding.2 Even though SBE is less complex and 
has less anchoring capacity, it has been reported to have the 
same types of complications as those seen in DBE. Safety data 
on SBE are still scarce, but may be comparable to those of DBE.8 
Active CD or previous intestinal surgery may increase the 
risk of perforation and hydrostatic balloon dilation of short 
fibrotic strictures in patients with SB CD has a small, but de-
finable risk of perforation (0% to 3%). Additionally, BAE in-
volves risks related to sedation, in contrast to SBCE where no 
sedation is required.
Spiral enteroscopy
Enteroscopy with the Endo-Ease System (Spirus Medical, 
Stoughton, MA, USA) uses a spiral-shaped overtube of 118 cm 
with a spiral of 0.55 cm high and 22 cm long and can be used 
with enteroscopes of less than 9.4 mm in diameter. The en-
teroscope is advanced or withdrawn with rotator clock-wise 
and counterclockwise movements of the spiral. Endoscopy of 
the SB by spiral enteroscopy is reported to be safe and seems 
to reduce the examination time, but the insertion extent is sh-
orter in comparison to DBE. In CD patients, spiral enteros-
copy has rarely been performed up to now.2 The feasibility of 
the technique has not been demonstrated in patients with CD, 
and no study has compared spiral enteroscope with other en-
doscopic techniques. Spiral enteroscopy is suspected by many 
to have a higher change of perforation and volvulus, but the 
very limited reports on this procedure does not provide us 
with a fair assessment of its safety. This form of procedure has 
recently become vastly limited because of the reported stop-
page of manufacturing of the spiral overtube in favor of a mo-
torized design with a short spiral. 
Radiology in imaging SB
Cross-sectional enterography provides complementary in-
Table 2. Balloon-Assisted Enteroscopy: Technical Data of the Scopes Those Are Presently Available
Device Company
Working 
channel, mm 
Length, 
cm
Working 
length, cm
Diameter of 
distal part, mm
Length of 
overtube, cm
Diameter of 
overtube, mm
DBE EN-450P5 Fujinon 2.2 230 200 8.5 145 13.2 (outer diameter) 
10.8 (inner diameter)
DBE EN-450T5 Fujinon 2.8 230 200 9.4 145 13.2 (outer diameter) 
10.8 (inner diameter)
SBE SIF-Q180 Olympus 2.8 230 200 9.2 132 13.2 (outer diameter) 
11  (inner diameter)
DBE, double balloon enteroscopy; SBE, single balloon enteroscopy.
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formation to ileocolonoscopy. Visualization of the SB with 
cross-sectional imaging methods requires distension of the in-
testines to identify the configuration of the bowel loops and 
to improve characterization of the bowel wall with luminal 
contrast. This is achieved by inserting a nasojejunal tube into 
the proximal SB (enteroclysis) or with oral intake of the lumi-
nal contrast medium (enterography). Conventional fluoros-
copy (barium SB radiographs: SB follow through and SB en-
teroclysis) has thereby almost completely been replaced by 
cross-sectional imaging methods. 
CTE and MRE
Among diverse diagnostic imaging modalities, during the 
recent decade, computed tomography (CT) and MR techni-
ques have been optimized for SB imaging with increasing role 
in the evaluation of SB diseases, especially of CD. CT and MR 
are available as CTE or MRE with oral intake providing simi-
lar quality images but with an improved patient comfort over 
tube-assisted infusion of enteral contrast.
With the improved resolution of multidetector CT, CTE 
has become an important method of choice for evaluating SB 
diseases, determination of disease activity, the extent, and se-
verity of inflamed bowel.23,24
On CTE, CT findings indicative of active inflammation 
include bowel wall thickening (thickness of >3 mm), mural 
stratification, mural hyperenhancement, increased attenuation 
in the perienteric fat and engorged vasa recta (comb sign).23,25
Although the diagnostic yield of CTE has been shown to 
be inferior to SBCE in suspected and established SB CD,26 
CTE have high sensitivities (95.2%) for detecting active SB 
inflammation. In addition, both CTE and MRE equally pro-
vide excellent information on extraenteric manifestations 
and complications including abscess, fistula, and bowel ob-
struction, thus adding useful information on endoscopic in-
vestigations.27 However, because patients with CD are often 
young and CD is a chronic and relapsing disease, they may 
undergo repeated imaging examinations to assess the status 
of their disease. Thus, large lifetime dose of radiation is a con-
cern particularly in young patients with CD. Radiation dose 
of more than 100 mSv may be observed in some patients. Ef-
forts should be made to reduce radiation dose in these pa-
tients by minimizing CT examination, dose reduction (using 
the dose modulation option or advanced reconstruction tech-
niques), or considering another diagnostic imaging modality.
For this reason, MRE has been introduced as a radiation-
free alternative method to evaluate patients with CD.28,29 MRE, 
these days, is well suited to play an important role in the evalu-
ation of SB disorders. In recent prospective studies, MRE was 
found to have a similar accuracy, area under the receiver op-
erating characteristics curve and sensitivity for detecting ac-
tive inflammation in CD compared with CTE.27,30,31 In addi-
tion, MRE has the potential advantage of providing functional 
and quantitative information about bowel wall (e.g., diffusion, 
perfusion, or motility) that cannot be obtained by CT.  In some 
CD patients with strictures, it is important to distinguish be-
tween inflammatory stricture and fixed fibrotic stricture, as ob-
struction and spasm in active CD may be relieved by medical 
treatment whereas chronic strictures may require surgical in-
tervention. MRE can provide useful information in this set-
ting by differentiating between fixed fibrostenotic lesions by 
depicting fat-halo sign and inflammatory stricture.9 
Early mucosal lesions such as aphthoid lesions, however, 
are not accurately visualized on CT or MR, making them less 
suitable as a first-line examination for suspected early diseas-
es. Therefore, until now, CTE appears to be more cost-effec-
tive in the long term assessment and follow-up of patients, 
especially those with established CD. Although MRE is being 
used more frequently because of the advantage of lack of ra-
diation, some limitation of MRE such as high cost, longer ex-
amination time, and slightly inferior spatial resolution than 
CTE, hardly makes it the initial imaging modality of choice 
in many adult patients.
 
OTHER MODALITIES FOR DETECTION 
OF SB CD
Percutaneous ultrasonography (US) is useful to detect SB 
CD and to reveal extraenteric complications, for example, ab-
scess or fistula. Overall accuracy might be lower compared with 
endoscopy, but an experienced investigator can beneficially use 
US as an initial diagnostic tool for managing CD patients.32
The main US findings in CD are represented by thickening 
and stiffness of the gut wall, modifications or lack of its 
echostratification, reduction of peristalsis, mesenteric fibro-
fatty proliferation, lymph node enlargement; in case of com-
plications, narrowing of the intestinal lumen, abscesses and 
fistula are usually easily detectable.33 
Labeled-leukocyte scintigraphy in detecting active inflam-
mation of CD has been evaluated. 99mTC HMPAO labeled 
white blood cell scan is a commonly used agent because of 
its greater availability, better image quality and lower radia-
tion dose.34 The sensitivity and specificity of leukocyte-la-
beled scintigraphy has been reported to range 76% to 94.7% 
and 77.8% to 93.3%, respectively.30 Recent studies on 18F-flu-
orodeoxyglucose positron emission tomography (FDG-PET) 
in assessing active CD reveals lower specificity values com-
pared to MR.35 The usefulness of PET in differentiating be-
tween active and indolent CD is still unclear.
 Park SJ et al.
  267
DIAGNOSTIC STRATEGY OF SB  
IN DIFFERENT CLINICAL SITUATIONS
In suspected CD, ileocolonoscopy is still the reference st-
andard in the diagnostic algorithm. It is used to diagnose ter-
minal ileitis or colitis, followed by cross-sectional imaging in-
cluding CTE or MRE to identify proximal CD or extraenteric 
lesions. SBCE is regarded a final identifier for detection of SB 
lesions that are reasons of unexplained symptoms. On the 
other hand, high negative predictive value of SBCE of 96% to 
100% suggests using SBCE to exclude CD in suspected dis-
ease cases.8 SBCE could be considered an early step in sus-
pected CD and nonconclusive ileocolonoscopy in the future.2 
In established CD, value of cross-sectional imaging sur-
passes endoscopic information in many clinical scenarios such 
as septic patients and acute onset of severe complaints and 
pain. The role of SBCE in patients with established CD should 
focus on patients with unexplained symptoms when other 
investigations are inconclusive, if this will alter management. 
Radiographic imaging takes precedence over SBCE because 
it can potentially identify obstructive strictures, extraenteric 
disease, transmural nature, or anatomic distribution of dis-
ease.8 CTE or MRE may also give an indication of disease ac-
tivity. The high potential for capsule retention in established 
CD should also be considered. Advantages and disadvantages 
of different SB imaging techniques are summarized in Table 3.
CONCLUSIONS
Although conventional ileocolonoscopy is the first diag-
nostic tool in patients with suspected CD, SB is the only site 
involved in as many as 30% of patients with CD. Therefore, 
SB imaging is a crucial element in diagnosing SB CD, and con-
tinues to evolve because of technologic and basic science ad-
vances. SB endoscopy (SBCE or DAE) and cross-sectional 
imaging (CTE or MRE) have become key players to diagnose 
and/or manage CD patients. SBCE shows the highest diag-
nostic yield in patients with suspected CD, but SBCE should 
be performed in patients with non-stricturing SB CD to avoid 
capsule retention. DAE, especially DBE, has advantages in 
therapeutic capabilities including balloon dilation or bleed-
ing control. On the other hand, CTE and MRE are noninvasive 
modalities that allow both luminal and extraluminal evalua-
tions. In everyday practice, the choice of the imaging modali-
ties is based on the presence and the availability of the tech-
niques and of experienced operators in each institute, clinical 
usefulness, safety, and cost.
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